Boston-based Aura Biosciences is implementing a significant workforce reduction. The biotechnology company will lay off 20% of its employees. This move is part of a strategic shift to concentrate on ocular oncology. The company anticipates incurring restructuring charges between $2.9 million and $3.2 million. This decision reflects a refocusing of the company's priorities.
Boston, MA
https://www.nbcboston.com/boston-business-journal/boston-biotech-to-cut-20-of-workforce/3996623/